Thyroxine restores severely impaired cutaneous re-epithelialisation and angiogenesis in a novel preclinical assay for studying human skin wound healing under "pathological" conditions ex vivo.
Journal Information
Full Title: Arch Dermatol Res
Abbreviation: Arch Dermatol Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest The authors state no conflict of interests, as this work was part of a strictly academic MD thesis project (of H.P., supervised by R.P.) that did not receive any industrial funding and did not lead to patent filing. For the record, R.P. is founder and managing owner of a company that also offers human skin wound-healing assays (www.monasteriumlab.com)."
"Compliance with ethical standards: Conflict of interestThe authors state no conflict of interests, as this work was part of a strictly academic MD thesis project (of H.P., supervised by R.P.) that did not receive any industrial funding and did not lead to patent filing. For the record, R.P. is founder and managing owner of a company that also offers human skin wound-healing assays (www.monasteriumlab.com). Conflict of interest: The authors state no conflict of interests, as this work was part of a strictly academic MD thesis project (of H.P., supervised by R.P.) that did not receive any industrial funding and did not lead to patent filing. For the record, R.P. is founder and managing owner of a company that also offers human skin wound-healing assays (www.monasteriumlab.com)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025